B44.7

Clinical Causes: Prolonged immune suppression due to chemotherapy, organ transplantation, or HIV/AIDS Pre-existing lung diseases such as chronic obstructive pulmonary disease (COPD) or tuberculosis Use of corticosteroids or other immunosuppressive medications Underlying hematological disorders like leukemia Breakdown of the body's natural defenses allowing fungi to invade and spread

Key Symptoms: Fever that does not resolve with antibiotics Respiratory symptoms such as cough, wheezing, or chest pain Shortness of breath or difficulty breathing Unexplained fatigue and weakness Signs of organ involvement, such as neurological symptoms if the brain is affected Skin lesions or areas of necrosis in cases where the skin is involved Weight loss and night sweats in advanced cases

Diagnosis Path: Diagnosing disseminated aspergillosis involves a combination of clinical assessment and diagnostic testing. Laboratory investigations typically include blood tests, cultures, and imaging studies. A tissue biopsy may be necessary to confirm the presence of fungi. Imaging techniques like CT scans can reveal lesions in the lungs or other organs, guiding diagnosis. Blood tests for fungal markers such as galactomannan or beta-D-glucan can support the suspicion of fungal infection.

Treatment Protocols: Management of disseminated aspergillosis involves aggressive antifungal therapy. Common medications include voriconazole, amphotericin B, or itraconazole. In some cases, combination therapy may be employed for more effective results. Addressing underlying immune deficiencies and reducing immunosuppressive therapies, when feasible, are crucial components of care. Supportive treatments might include oxygen therapy, nutritional support, and management of organ-specific complications. Early intervention improves prognosis and reduces the risk of severe outcomes.